Volume 8 | Issue - 10
Volume 8 | Issue - 10
Volume 8 | Issue - 10
Volume 8 | Issue - 10
Volume 8 | Issue - 9
Felbamate acknowledged as an antiepileptic medicine since the 1990s, has garnered scientific interest due to its unique pharmacological properties and potential therapeutic uses beyond epilepsy. This comprehensive scientific review aims to thoroughly examine felbamate's chemistry, focusing on its mechanisms of action, which include the modulation of NMDA and GABA receptors. These actions contribute to its antiepileptic efficacy and its potential in synaptic plasticity and neuroprotection, thus providing versatility for potential neurological uses. The review also assesses felbamate's therapeutic efficacy, especially in treatment-resistant epilepsy, where standard medications often fail. Additionally, the safety profile is evaluated, highlighting risks such as aplastic anemia and hepatic dysfunction, essential for risk-benefit analysis. Significantly, considerable scientific interest in felbamate extends beyond its use in treating epilepsy. Ongoing research efforts are shedding light on its potential neuroprotective properties, particularly in the context of neurodegenerative disorders like Alzheimer's and Parkinson's disease. This interest is driven by felbamate's ability to regulate synaptic plasticity and reduce neuroinflammatory processes. This study provides a comprehensive overview of the current scientific understanding of felbamate, encompassing its various mechanisms, clinical effectiveness, safety issues, and potential avenues for future research. The unique pharmacological profile of felbamate, along with its increasing application in the field of neurology, solidifies its status as a topic of ongoing scientific inquiry and highlights its potential importance in neurological treatments.